May 19, 2017

FDA Extends Intended Uses Rule Comment Period to July 18

The FDA extended the comment period on its “intended uses” rule an additional 60 days to July 18. In March, the agency had pushed back the effective date of the rule until March 19, 2018, and noted it had received a petition, which “raises questio...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight